Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades

Zhang, Lei; Liu, Qi; Huang, Shiew‐Mei; Lionberger, Robert

doi:10.1124/dmd.121.000706

Cited by 5 publications

(2 citation statements)

References 57 publications

(59 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to passive glomerular filtration, drugs are eliminated into the urine by active drug transport systems (involving tubular secretion and reabsorption) in the proximal renal tubules [ 3 ]. Solute carrier (SLC) membrane transporters play an important role in the metabolism and excretion of small-molecule drugs [ 4 , 5 ]. Important renal transporters involved in this process include the organic cation transporters (OCTs), multidrug and toxin efflux proteins (MATEs) and organic anion transporters (OATs) (Fig.…”

Section: Introductionmentioning

confidence: 99%

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Choi,

Madari,

Huang

2024

Clin Pharmacokinet

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Choi,

Madari,

Huang

2024

Clin Pharmacokinet

View full text Add to dashboard Cite

“…Lei Zhang obtained her Ph.D. with Dr. Giacomini and is deputy director of the Office of Research and Standards, Office of Generic Drugs at the Center for Drug Evaluation and Research, at the FDA. Dr. Zhang and her colleagues contribute the article, "Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades" (Zhang et al, 2022), which summarizes Dr. Giacomini's key contributions and influences on transporters in regulatory science through her collaborations with FDA scientists. The article highlights the founding of the International Transporter Consortium and its workshops and white papers.…”

mentioning

confidence: 99%

Special Section on New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters–Editorial

Lai¹,

Zhong²

2022

Drug Metab Dispos

View full text Add to dashboard Cite

In the current issue of Drug Metabolism and Disposition (DMD), Dr. Kathleen M. Giacomini, a world-renowned leader in membrane transporter biology, pharmacogenomics, and regulatory sciences, along with and several of her former trainees contribute a special section titled, "New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters." After obtaining her bachelor's degree in pharmacy from the University of Houston, Dr. Giacomini received her Ph.D. in pharmaceutics from the State University of New York at Buffalo and completed postdoctoral training at Stanford University. She has been a faculty member of University of California, San Francisco (UCSF) since 1982 and was recently named dean of the UCSF School of Pharmacy. She is a cofounder of the International Transporter Consortium, which brings together scientists from academia, industry, and regulatory agencies worldwide to advance knowledge of transporters in drug development with the goal of improving human health. She is also a co-director of the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation in partnership with the US Food and Drug Administration (FDA). Dr. Giacomini is the recipient of numerous awards for her seminal work in membrane transporter genomics and the role these proteins have in drug targeting, disposition, and response. Some of her notable honors include the North American Scientific Achievement Award from the International Society for the Study of Xenobiotics, the Volwiler Research Achievement Award and Paul Dawson Biotechnology Award given by the American Association of Colleges of Pharmacy, the Rawls-Palmer Progress in Medicine Award from the American Society for Clinical Pharmacology and Therapeutics, the Bill Heller Mentor of the Year Award from the American Foundation for Pharmaceutical Education, the Bernard B. Brodie Award from the Division for Drug Metabolism and Disposition of the American Society of Pharmacology and Experimental Therapeutics (Fig. 1), and the Distinguished Pharmaceutical Scientist Award given by the American Association of Pharmaceutical Scientists.Membrane transporters play a major role in human physiology and in drug disposition and response. In 1997, Dr. Giacomini's laboratory cloned and characterized the first human polyspecific organic cation transporter from liver (Zhang et al., 1997), which was almost simultaneously cloned in another laboratory (Gorboulev et al., 1997), and discovered that variants in the gene were associated with the disposition of and response to the antidiabetic drug metformin (Shu et al., 2007). Recently, her group unraveled the functional role of the orphan solute carrier (SLC) 22A24, an anion exchanger that preferentially transports steroid glucuronide conjugates (Yee et al., 2019).Dr. Giacomini trained over 35 graduate students and 30 postdoctoral fellows with many of those trainees becoming national and international leaders in the pharmaceutical sciences. Dr. Sook Wah Yee was a postdoctoral fellow under Dr. Giacomini and is currently a ...

show abstract

Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel

Yue

Ran

Xin

et al. 2023

Journal of Pharmaceutical Analysis

View full text Add to dashboard Cite

Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades

Cited by 5 publications

References 57 publications

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Special Section on New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters–Editorial

Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel

Contact Info

Product

Resources

About